Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.
J Nephrol. 2012 Mar-Apr;25(2):262-5. doi: 10.5301/jn.5000065.
The idiopathic systemic capillary leak syndrome (SCLS) is a rare life-threatening disorder characterized by periodic episodes of hypovolemic shock, due to plasma leakage from the intravascular to the interstitial space, as reflected by accompanying hypoalbuminemia, hemoconcentration and edema. Here we report the case of a 65-year-old woman affected by SCLS who required aggressive resuscitation with norepinephrine, steroids, albumin and crystalloids. Then, a long-term prophylaxis with a ß(2)-adrenergic receptor agonist and theophylline was started. In conclusion, though SCLS is a rare entity, the associated morbidity and mortality require the physician's awareness to provide timely therapy. Underrecognition in the medical community and rarity of this syndrome have precluded analysis by rational clinical trial designs that are necessary to determine more targeted and adequate therapy. This report is meant to enhance awareness of SCLS in the nephrology community.
特发性全身性毛细血管渗漏综合征(SCLS)是一种罕见的危及生命的疾病,其特征为周期性低血容量性休克,由于血浆从血管内渗漏到细胞外间隙,导致低白蛋白血症、血液浓缩和水肿。本文报道了一例 65 岁女性 SCLS 患者,该患者需要使用去甲肾上腺素、类固醇、白蛋白和晶体液进行积极复苏。然后,开始使用β(2)-肾上腺素能受体激动剂和茶碱进行长期预防。总之,尽管 SCLS 是一种罕见的疾病,但相关的发病率和死亡率需要医生的认识,以提供及时的治疗。医学界对该病认识不足,这种综合征也很少见,这使得通过合理的临床试验设计进行分析变得不可能,而这些分析对于确定更有针对性和更充分的治疗是必要的。本报告旨在提高肾脏病学界对 SCLS 的认识。